Neogenomics, Inc.
NEO
$16.05
$0.211.33%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 145.54M | 146.14M | 159.62M | 164.12M | 163.69M |
| Total Receivables | 175.87M | 167.82M | 159.24M | 155.80M | 153.63M |
| Inventory | 27.14M | 29.84M | 28.57M | 28.46M | 34.17M |
| Prepaid Expenses | 23.59M | 23.67M | 21.44M | 21.99M | 22.83M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 9.34M | 6.21M | 7.42M | 12.11M | 18.24M |
| Total Current Assets | 381.48M | 373.68M | 376.29M | 382.47M | 392.55M |
|
|
|||||
| Total Current Assets | 381.48M | 373.68M | 376.29M | 382.47M | 392.55M |
| Net Property, Plant & Equipment | 166.20M | 160.36M | 163.28M | 165.62M | 168.33M |
| Long-term Investments | 524.00M | 524.00M | 524.34M | 524.34M | 524.14M |
| Goodwill | 524.00M | 524.00M | 524.34M | 524.34M | 524.14M |
| Total Other Intangibles | 271.26M | 278.90M | 286.53M | 294.16M | 301.80M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 9.31M | 9.60M | 9.39M | 8.19M | 7.13M |
| Total Assets | 1.35B | 1.35B | 1.36B | 1.37B | 1.39B |
|
|
|||||
| Total Accounts Payable | 20.95M | 25.90M | 23.09M | 22.61M | 27.49M |
| Total Accrued Expenses | 69.31M | 53.30M | 59.58M | 68.69M | 67.04M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.43M | 4.83M | 4.78M | 4.51M | 4.05M |
| Total Finance Division Other Current Liabilities | 10.19M | 561.00K | 851.00K | 2.05M | 1.54M |
| Total Other Current Liabilities | 10.19M | 561.00K | 851.00K | 2.05M | 1.54M |
| Total Current Liabilities | 105.88M | 84.59M | 88.30M | 97.87M | 100.12M |
|
|
|||||
| Total Current Liabilities | 105.88M | 84.59M | 88.30M | 97.87M | 100.12M |
| Long-Term Debt | 374.24M | 342.24M | 341.86M | 341.48M | 341.10M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 68.70M | 61.46M | 62.82M | 64.33M | 66.62M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 17.69M | 29.48M | 30.29M | 32.82M | 32.08M |
| Total Liabilities | 566.51M | 517.77M | 523.27M | 536.49M | 539.91M |
|
|
|||||
| Common Stock & APIC | 1.26B | 1.28B | 1.27B | 1.26B | 1.25B |
| Retained Earnings | -448.67M | -450.91M | -433.81M | -423.93M | -396.80M |
| Treasury Stock & Other | -25.00M | 4.00K | 4.00K | 71.00K | 29.00K |
| Total Common Equity | 785.73M | 828.76M | 836.56M | 838.29M | 854.04M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 785.73M | 828.76M | 836.56M | 838.29M | 854.04M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 785.73M | 828.76M | 836.56M | 838.29M | 854.04M |
|
|
|||||